Is hepatitis C direct-acting antiviral therapy a risk factor for the development and recurrence of hepatocellular carcinoma? Narrative literature review and clinical practice recommendations.

Annals of Hepatology
Carolina Delgado MartínezCecilia Gómez-Domínguez

Abstract

The development of direct-acting antivirals (DAAs) has been a turning point in chronic hepatitis C treatment. With an efficacy rate on viral eradication close to 100% and an excellent safety profile, they have replaced interferon-based treatments as first-line therapy for hepatitis C virus (HCV). Following the encouraging results observed during the first years with these treatments, new publications suggested an unexpectedly high incidence of hepatocellular carcinoma (HCC) in patients previously treated with DAAs as well as a higher HCC recurrence rate in them. The possible interaction between DAAs and HCC and its impact on HCC incidence and recurrence still remains controversial. The aim of the present work is to review the current state of the matter by analyzing studies that evaluate the association between chronic hepatitis C treatment with DAAs and the development of HCC either de novo or as a recurrence. Following this, clinical practice recommendations are done.

References

May 19, 2007·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·George N IoannouSum P Lee
Nov 3, 2009·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·Ashwani K SingalGagan K Sood
Jul 28, 2010·Alimentary Pharmacology & Therapeutics·A K SingalB S Anand
Jun 12, 2016·Journal of Hepatology·UNKNOWN ANRS collaborative study group on hepatocellular carcinoma (ANRS CO22 HEPATHER, CO12 CirVir and CO23 CUPILT cohorts). Electr
Jan 29, 2017·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Julie K HeimbachJorge A Marrero
Apr 8, 2017·Seminars in Liver Disease·María ReigJordi Bruix
Jun 20, 2017·Journal of Hepatology·Hiroko NagataUNKNOWN Ochanomizu Liver Conference Study Group
Jun 24, 2017·Gastroenterology·Fasiha KanwalHashem B El-Serag
Jul 26, 2017·Nature Reviews. Clinical Oncology·Wolf H FridmanGuido Kroemer
Jul 28, 2017·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Lisa I BackusLarry A Mole
Dec 6, 2017·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Darrick K LiAdeel A Butt
Feb 25, 2018·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Annsa C HuangNorah A Terrault
Apr 7, 2018·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Jorge A MarreroJulie K Heimbach
Apr 10, 2018·Journal of Hepatology·UNKNOWN European Association for the Study of the Liver. Electronic address: easloffice@easloffice.eu, UNKNOWN European Association for the Study of the Liver
Apr 14, 2018·Journal of Hepatology·UNKNOWN European Association for the Study of the Liver. Electronic address: easloffice@easloffice.eu, UNKNOWN European Association for the Study of the Liver
Apr 16, 2018·Gastroenterology·Vincenza CalvarusoUNKNOWN Rete Sicilia Selezione Terapia–HCV (RESIST-HCV)
Oct 20, 2018·Journal of Hepatology·Mizuki Nishibatake KinoshitaKazuhiko Koike
Dec 24, 2018·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·Hooman Farhang ZangnehJordan J Feld
Jan 14, 2019·Liver International : Official Journal of the International Association for the Study of the Liver·Federico PiñeroUNKNOWN LALREAN
Jun 7, 2019·Clinical Liver Disease·Feng Su, George N Ioannou
Oct 22, 2019·Lancet·C Wendy SpearmanMark Sonderup

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antivirals

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Antivirals (ASM)

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.